Clinical trial
Ranolazine Mediated Premature Ventricular Contraction Reduction in Ischemic Heart Disease
NCT02360397 is registered in ClinicalTrials.gov with Kent Hospital, Rhode Island as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ranolazine Mediated Premature Ventricular Contraction Reduction in Ischemic Heart Disease
- Lead sponsor
- Kent Hospital, Rhode Island
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- February 23, 2018
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.